Cutia Therapeutics (HKG:2487)
Hong Kong · Delayed Price · Currency is HKD 0.8600
+0.0100 (1.18%)
Oct 9, 2026, 3:26 PM HKT
Cutia Therapeutics Market Cap
Cutia Therapeutics has a market cap or net worth of 319.06 million as of October 9, 2026. It is the 31,922nd most valuable company in the world and the 1,666th biggest in Hong Kong. Its market cap has decreased by 89.78% in one year.
Market Cap
319.06M
Enterprise Value
-86.96M
Revenue
383.95M
Global Rank
Country Rank
#1,666 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since June 12, 2023, Cutia Therapeutics's market cap has decreased from 6.67B to 319.06M, a decrease of -95.22%. That is a compound annual growth rate of -59.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 319.06M | -80.66% |
| Dec 31, 2025 | 1.65B | -26.86% |
| Dec 31, 2024 | 2.26B | -32.43% |
| Dec 29, 2023 | 3.34B | -49.98% |
| Jun 12, 2023 | 6.67B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sunho Biologics | 970.43M |
| Kintor Pharmaceutical | 807.38M |
| Brii Biosciences | 620.79M |
| 3D Medicines | 587.75M |
| B&K Corporation | 493.57M |
| Wuhan YZY Biopharma | 484.62M |
| Uni-Bio Science Group | 417.99M |
| Sirnaomics | 413.27M |